354 related articles for article (PubMed ID: 25835269)
1. Superficial venous disease and combined hormonal contraceptives: a systematic review.
Tepper NK; Marchbanks PA; Curtis KM
Contraception; 2016 Sep; 94(3):275-9. PubMed ID: 25835269
[TBL] [Abstract][Full Text] [Related]
2. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
3. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J; Bardenheuer K; Heinemann K
Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
6. Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.
Geersing GJ; Cazemier S; Rutten F; Fitzmaurice DA; Hoes AW
BMJ Open; 2018 Apr; 8(4):e019967. PubMed ID: 29678975
[TBL] [Abstract][Full Text] [Related]
7. Progestin-only contraception and thromboembolism: A systematic review.
Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
[TBL] [Abstract][Full Text] [Related]
8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
9. First venous thromboembolism and hormonal contraceptives in young French women.
Hugon-Rodin J; Horellou MH; Conard J; Flaujac C; Gompel A; Plu-Bureau G;
Medicine (Baltimore); 2017 Aug; 96(34):e7734. PubMed ID: 28834877
[TBL] [Abstract][Full Text] [Related]
10. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
[TBL] [Abstract][Full Text] [Related]
11. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study.
Galanaud JP; Genty C; Sevestre MA; Brisot D; Lausecker M; Gillet JL; Rolland C; Righini M; Leftheriotis G; Bosson JL; Quere I;
Thromb Haemost; 2011 Jan; 105(1):31-9. PubMed ID: 20886192
[TBL] [Abstract][Full Text] [Related]
13. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.
Sidney S; Petitti DB; Soff GA; Cundiff DL; Tolan KK; Quesenberry CP
Contraception; 2004 Jul; 70(1):3-10. PubMed ID: 15208046
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
16. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with the development of superficial vein thrombosis in patients with varicose veins.
Karathanos C; Exarchou M; Tsezou A; Kyriakou D; Wittens C; Giannoukas A
Thromb Res; 2013 Jul; 132(1):47-50. PubMed ID: 23768449
[TBL] [Abstract][Full Text] [Related]
19. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
20. Hormonal contraception and thrombosis.
Sitruk-Ware R
Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
